期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

替吉奥治疗胃癌的临床新进展 被引量：4

Progress in Clinical Treatment of Gastric Cancer with Gio
下载PDF
导出
摘要 替吉奥胶囊是替加氟及优福定的升级换代产品,毒副作用小,疗效确切,给药方便,在不断的临床应用及临床试验当中,它展示了对胃癌治疗的良好效果,在将来有望成为胃癌治疗的一线治疗药物。 Gio capsules tegafur and UFT upgrade products had drug side effects, efficacy, ease of administration, which continued in clinical applications and clinical trials, which demonstrated good effects for the treatment of gastric cancer.In the future, durg is expected to become first-line treatment of gastric cancer treatments.
作者 张麒
机构地区 云南省肿瘤医院腹部外科
出处 《现代诊断与治疗》 CAS 2013年第18期4137-4138,共2页 Modern Diagnosis and Treatment
关键词 替吉奥 胃癌 进展 Gio Gastric cancer Progress
分类号 R735.2 [医药卫生—肿瘤]
  • 相关文献

参考文献8

二级参考文献51

  • 1秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量：268
  • 2李献文,金建华,王芳,陆文斌,顾小燕,张华,杨玉薇.多西紫杉醇联合奥沙利铂和5-氟尿嘧啶治疗晚期胃癌41例[J].新乡医学院学报,2007,24(2):178-180. 被引量：12
  • 3孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2009.
  • 4Shirasaka T,Shimamoto Y,Ohshimo H,et al[J].Development of a novel form of an oral S-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators[J].Anticancer Drugs,1996; 7; 548 -557.
  • 5Ikeda K,Yoshisue K,Matsushima E,et al.Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P -450 2A6 in human liver microsomes in vitro[J].Clin Cancer Res,2000; 6:4409 -4415.
  • 6Tatsumi K,Fukushima M,Shirasaka T,et al.Inhibitory effects of pyrimidine,barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rats liver extracts[J].Jpn J Cancer Res,1987; 78:748-755.
  • 7Shirasaka T,Shimamoto Y,Fukushima M.Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats[J].Cancer Res,1993 ;53:4004-4009.
  • 8Shirasaka T.Development history and concept of an oral anticancer agent S-1 (TS-1):Its clinical usefulness and future vistas[J].Jpn J Clin Oncol,2009; 39:2 -15.
  • 9Hirata K,Horikoshi N,Aiba K,et al.Pharmacokinetic study of S -1,a novel oral fluorouracil antitumor drug[J].Clin Cancer Res,1999;5:2000-2005.
  • 10Peters GJ,Noordhuis P,van Kuilenburget AB,et al.Pharmacoki-netics of S -1,an oral formulation of ftorafur,oxonic acid and S -chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors[J].Cancer Chemother Pharmacol,2003; 52:1 -12.

共引文献88

同被引文献31

引证文献4

二级引证文献10

现代诊断与治疗
2013年 第18期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部